EyePoint Pharmaceuticals, Inc.

NASDAQ:EYPT

Biotechnology

Healthcare
$2.99 +1.98%

+$0.26 today

Market cap
$250.69M
Beta
1.75
P/E (TTM)
-4.2
EPS (TTM)
-$3.16
52W Low $7.94High $19.11

Volume 2.75M

Average 0.95M

Price history

EyePoint Pharmaceuticals, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-79.06%

Period high

$18.85

Period low

$2.99

Latest

$2.99

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/AOct 7, 2026Oct 7, 2026
8-KSep 10, 2026Sep 10, 2026
SC 13GSep 8, 2026Sep 8, 2026
4Aug 24, 2026Aug 24, 2026
4Aug 18, 2026Aug 18, 2026
8-KAug 17, 2026Aug 17, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 12, 2026Aug 12, 2026
S-8Aug 5, 2026Aug 5, 2026
8-KAug 5, 2026Aug 5, 2026
10-QAug 5, 2026Aug 5, 2026
SC 13GJul 31, 2026Jul 31, 2026
8-KJul 30, 2026Jul 30, 2026
SC 13G/AJul 28, 2026Jul 28, 2026
8-KJul 17, 2026Jul 17, 2026

Competitors

Who does EyePoint Pharmaceuticals, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about EYPT's filings, answered from its disclosures.

What is the latest EYPT filing?

The latest filing shown is SC 13G/A dated Oct 7, 2026.

How many recent filings does EYPT have?

Intrinsic Alpha currently shows 20 recent filings for EYPT.